Bactiguard Holding AB (CHIX:BACTBS) Buyback Yield %: 0.00 (As of Jul. 03, 2026)


CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
59 GF Score
Price kr128.60
GF Value kr274.02
! 2 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Buyback Yield %?

Bactiguard Holding AB CHIX:BACTBS 59 Buyback Yield % is 0.00 as of Jul. 03, 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 59/100 and a GF Value™ of kr274.02. The stock has 2 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Bactiguard Holding AB ranks worse than 288184.15% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Bactiguard Holding AB's current buyback yield was 0.00%.


Bactiguard Holding AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB Buyback Yield % Chart

Bactiguard Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.97 0.00 0.00 0.00 0.00

Bactiguard Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CHIX:BACTBS vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, Bactiguard Holding AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bactiguard Holding AB Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Bactiguard Holding AB's Buyback Yield % falls into.


CHIX:BACTBS
59GF Score
Bactiguard Holding AB CHIX:BACTBS
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Bactiguard Holding AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 4506.6584
=0.00%

Bactiguard Holding AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 4506.6584
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Buyback Yield % of 0.00 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bactiguard Holding AB and its competitors. According to the industry distribution chart, Bactiguard Holding AB ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Bactiguard Holding AB's Buyback Yield % too high?
Bactiguard Holding AB's current Buyback Yield % is 0.00. Based on the distribution chart, Bactiguard Holding AB ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #999999 out of 347 companies for Buyback Yield %. This places Bactiguard Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Buyback Yield % of 0.00. The stock's GF Value™ is kr274.02, compared to a current price of kr128.60 — trading 53.1% below its estimated fair value. The current Buyback Yield % is 0.00. Bactiguard Holding AB's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Buyback Yield % is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 53.1% below its estimated GF Value™ of kr274.02.

Key valuation signals for CHIX:BACTBS:

  • Buyback Yield %: 0.00
  • GF Value™: kr274.02 vs. price of kr128.60 (53.1% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
59GF Score

Get the complete analysis for CHIX:BACTBS

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr274.02
GF Value